T. Rowe Price Associates’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

T. Rowe Price Associates’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-74,599	Closed	-$189K	–	3012
2023 Q4	$189K	Sell	74,599 -8,367	-10%	-$19.5K	﹤0.01%	2561
2023 Q3	$199K	Buy	82,966 +3,681	+5%	+$8.15K	﹤0.01%	2507
2023 Q2	$184K	Buy	79,285 +1,362	+2%	+$3.85K	﹤0.01%	2560
2023 Q1	$199K	Buy	77,923 +3,782	+5%	+$10.8K	﹤0.01%	2533
2022 Q4	$186K	Buy	74,141 +14,237	+24%	+$39.7K	﹤0.01%	2553
2022 Q3	$174K	Sell	59,904 -4,209,521	-99%	-$17.7M	﹤0.01%	2593
2022 Q2	$19.3M	Sell	4,269,425 -1,567,589	-27%	-$9.33M	﹤0.01%	1175
2022 Q1	$46.8M	Buy	5,837,014 +1,118,293	+24%	+$9.86M	﹤0.01%	988
2021 Q4	$54.9M	Buy	4,718,721 +2,903,722	+160%	+$34.8M	﹤0.01%	971
2021 Q3	$22.5M	Buy	+1,814,999	New	+$20.5M	﹤0.01%	1263

T. Rowe Price Associates's SLGC Position: Q1 2024 in Review

T. Rowe Price Associates sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 74,599 shares — an estimated $189K sold.

T. Rowe Price Associates first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $54.9M in Q4 2021. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

T. Rowe Price Associates reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
T. Rowe Price Associates sold 74,599 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $189K.
T. Rowe Price Associates first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
T. Rowe Price Associates's SomaLogic, Inc. Class A Common Stock position peaked at $54.9M in Q4 2021.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.